Forget Mediocre Spirit Sure Success
Bass
September 29, 2022
We’re tracking changes to college sports schedules caused by Hurricane Ian this week.
CNN reports that Ian has weakened into a tropical storm after after making landfall “along the southwestern coast of Florida near Cayo Costa as a powerful Category 4 hurricane Wednesday.”
Here are the latest changes to
Bass
July 30, 2022
Apple with iOS 16 added a new medication management feature to the Health app, which is designed to allow users to keep track of their medications to make sure a dose isn’t missed. The feature works alongside a new Medications app on the Apple Watch, and it’s useful for everything
Bass
March 29, 2022
Financial results demonstrate strong fundamentals
Twenty key clinical milestones achieved year-to-date, including positive data readouts for lemzoparlimab, uliledlimab and felzartamab
Seven business development deals, including a US$315M strategic commercial partnership with Jumpcan on eftansomatropin alfa
Global pipeline comprised of 10 clinical stage assets, mostly in phase 2 and phase 3
Bass
March 8, 2022
By The Associated Press
The latest developments on the Russia-Ukraine war:
MARIUPOL, Ukraine — Civilians in the besieged port of Mariupol in southeast Ukraine are anxiously waiting for news of evacuation efforts as they struggle to survive in a city where bodies have been left uncollected on the streets.
Bass
January 4, 2022
Festivities, including major parades that bring thousands to the streets, were largely canceled in 2021.
There had been concerns that the 2020 Mardi Gras celebration had been an unintended “super spreader” of coronavirus in the early days of the pandemic.
This year, city officials are moving ahead with plans for
Bass
November 8, 2021
University of Nebraska at Omaha (UNO) Chancellor Joanne Li, Ph.D., CFA, announced today a series of Office of Business and Finance updates that will support the unit’s mission of providing thoughtful stewardship of financial, infrastructure, and human resources.
Jim
Bass
September 6, 2021
13 significant clinical milestones achieved year-to-date, including critical positive data readout events for felzartamab (TJ202/MOR202), lemzoparlimab (TJC4), uliledlimab (TJD5), and plonmarlimab (TJM2) and more milestone achievements are expected before the year-end 2021
Felzartamab (TJ202/MOR202) is on track for Biologic License Application (BLA) submission in Q4 2021 and eftansomatropin alfa (TJ101)
growlerusaphoenix.com provide by The top global media Sports & Travel,Food & Cooking,Computer & Technology,Business & Finance,Home Improvement,Health & Fitness,Fashion & Shopping